Prof. Jinxue Tong 佟金学
Chief Physician, Professor
Department of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of gastrointestinal and breast tumors, including radical and extended radical colectomy, TME for rectal cancer, functional extended radical resection, and sphincter-preserving surgery for low and ultra-low rectal cancer.
Dr. Tong is a Chief Physician, Professor, Deputy Director of the Cancer Center, and Head of Ward 1, Surgical Oncology at Harbin Medical University Cancer Hospital. Holding a MD from Peking University, Dr. Tong serves as a master's supervisor. Research focuses on basic and clinical studies of colorectal cancer.
Professional roles
- Vice Chair, Colorectal Cancer Professional Committee, Heilongjiang Anti-Cancer Association
- Vice Chair, Breast Cancer Professional Committee, Heilongjiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Tong Jinxue). Papers usually list the name as Jinxue Tong or Tong J.
Selected publications
11 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- World J Gastroenterol, 2026 (senior author): Perioperative serum carcinoembryonic antigen: Powerful marker for prognostic prediction and adjuvant chemotherapy decision-making in patients with stage II and III colorectal cancer. PubMed 41810442
- Mediators Inflamm, 2026 (senior author): Analysis of Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Colorectal Cancer. PubMed 41902657
- Hum Mol Genet, 2022 (first author): The anti-inflammatory mechanism of SAHA in acute pancreatitis through HDAC5/SLIT2/Akt/β-catenin axis. PubMed 35022732
- Cell Biosci, 2022 (senior author): Blockade of the Arid5a/IL-6/STAT3 axis underlies the anti-inflammatory effect of Rbpjl in acute pancreatitis. PubMed 35725649
- J Cell Mol Med, 2019 (senior author): MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. PubMed 30338942
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion